First patient dosed in Immutep’s soft tissue sarcoma trial
The phase 2 study involves company’s eftilagimod alpha therapy
Read More
Tag: immutep
Immutep reveals commencement of vital phase 2 trial
Efti’s targeting activation of antigen-presenting cells delivers an adaptive immunity to fight cancer
Read More
Immutep reveals initiation of pivotal Efti study
The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer
Read More
Immutep in clinical trail collaboration with Merck KGaA and Pfizer
Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
